Table 2.
Concomitant conditions, n (%) | Total (N = 200) | TIRs (n = 88) | TSRs (n = 112) | p value |
---|---|---|---|---|
Neck pain | 26 (13.0) | 13 (14.8) | 13 (11.6) | 0.509a |
Anxiety | 9 (4.5) | 5 (5.7) | 4 (3.6) | 0.511b |
Stress | 13 (6.5) | 5 (5.7) | 8 (7.1) | 0.677a |
Sleep disorders | 8 (4.0) | 3 (3.4) | 5 (4.5) | 1.000b |
Depression | 5 (2.5) | 3 (3.4) | 2 (1.8) | 0.656b |
Asthma/allergic rhinitis | 9 (4.5) | 4 (4.5) | 5 (4.5) | 1.000b |
Back pain | 4 (2.0) | 2 (2.3) | 2 (1.8) | 1.000b |
Thyroid disease | 1 (0.5) | 0 | 1 (0.9) | 1.000b |
No. of diagnosed concomitant conditions, mean (SD) | 0.59 (1.0) | 0.56 (0.8) | 0.62 (1.1) | 0.664c |
Currently has a cardiovascular condition, n (%) | 27 (13.5) | 12 (13.6) | 15 (13.4) | 0.960a |
Hypertension | 25 (12.5) | 10 (11.4) | 15 (13.4) | 0.667a |
Angina | 1 (0.5) | 0 | 1 (0.9) | 1.000b |
Otherd | 3 (1.5) | 2 (2.3) | 1 (0.9) | – |
Current cardiovascular risk,e n (%) | 0.821a | |||
Mild | 169 (86.7) | 74 (86.0) | 95 (87.2) | |
Moderate | 26 (13.3) | 12 (14.0) | 14 (12.8) |
Percentages are calculated as proportion of non-missing data
PRF patient record form (completed by the physician), SD standard deviation, TIR triptan insufficient responders (based on efficacy), TSR triptan sufficient responders (based on efficacy)
aChi-square test for TSRs versus TIRs
bFisher’s exact test for TSRs versus TIRs
ct test for TSRs versus TIRs
dNo patient in either group had cerebrovascular disease, ischemic heart disease, congestive heart failure, hypotension, atrial fibrillation, arrhythmia, deep vein thrombosis, cardiomyopathy, coronary artery disease, peripheral vascular disease, mitral valve disease, or Raynaud’s disease
eSubjective opinion of the physician; no patient was assessed as being at severe risk